CADM1, MAL and miR124-2 methylation analysis in cervical scrapes to detect cervical and endometrial cancer

Journal of Clinical Pathology

Volumn 67, Issue 12, 2014, Pages 1067-1071

  De Strooper, Lise M A ^a   Van Zummeren, Marjolein ^a   Steenbergen, Renske D M ^a   Bleeker, Maaike C G ^a   Hesselink, Albertus T ^a   Wisman, G Bea A ^b   Snijders, Peter J F ^a   Heideman, Daniëlle A M ^a   Meijer, Chris J L M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CADM1 PROTEIN; MAL PROTEIN; MICRORNA 124; MICRORNA 124 2; TUMOR MARKER; UNCLASSIFIED DRUG; CADM1 PROTEIN, HUMAN; CELL ADHESION MOLECULE; IMMUNOGLOBULIN; MAL PROTEIN, HUMAN; MICRORNA; MIRN124 MICRORNA, HUMAN; MYELIN AND LYMPHOCYTE PROTEIN;

ADULT; AGED; ARTICLE; CARCINOGENESIS; DISEASE SEVERITY; DNA METHYLATION; EARLY CANCER; ENDOMETRIUM CANCER; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PROMOTER REGION; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; CERVICAL INTRAEPITHELIAL NEOPLASIA; ENDOMETRIAL NEOPLASMS; GENETICS; MIDDLE AGED; MULTIPLEX POLYMERASE CHAIN REACTION; NUCLEOTIDE SEQUENCE; PAPANICOLAOU TEST; REAL TIME POLYMERASE CHAIN REACTION; UTERINE CERVICAL NEOPLASMS; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; CELL ADHESION MOLECULES; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA METHYLATION; DNA MUTATIONAL ANALYSIS; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; IMMUNOGLOBULINS; MICRORNAS; MIDDLE AGED; MULTIPLEX POLYMERASE CHAIN REACTION; MYELIN AND LYMPHOCYTE-ASSOCIATED PROTEOLIPID PROTEINS; PAPANICOLAOU TEST; REAL-TIME POLYMERASE CHAIN REACTION; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84910138577     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jclinpath-2014-202616     Document Type: Article

References (46)

1. Ferlay J, Shin H-R, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893-917.
2. Zhou J, Tomashefski JF, Sawady J, et al. The diagnostic value of the ThinPrep pap test in endometrial carcinoma: a prospective study with histological follow-up. Diagn Cytopathol 2013;41:408-12.
3. Zhou J, Tomashefski JF, Khiyami A. Diagnostic value of the thin-layer, liquid-based Pap test in endometrial cancer: a retrospective study with emphasis on cytomorphologic features. Acta Cytol 2007;51:735-41.
4. Guidos BJ, Selvaggi SM. Detection of endometrial adenocarcinoma with the ThinPrep Pap test. Diagn Cytopathol 2000;23:260-65.
5. Schorge JO, Hossein Saboorian M, Hynan L, et al. ThinPrep detection of cervical and endometrial adenocarcinoma: a retrospective cohort study. Cancer 2002;96:338-43.
6. Kim S-S, Suh D-S, Kim K-H, et al. Clinicopathological significance of atypical glandular cells on Pap smear. Obstet Gynecol Sci 2013;56:76-83.
7. Muñoz N, Bosch FX, Castellsagué X, et al. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer 2004;111:278-85.
8. Arbyn M, Ronco G, Anttila A, et al. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer. Vaccine 2013;31:6266.
9. Ronco G, Giorgi-Rossi P, Carozzi F, et al. Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test. J Natl Cancer Inst 2008;100:492-501.
10. Gök M, Heideman DAM, van Kemenade FJ, et al. HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study. BMJ 2010;340:c1040.
11. Szarewski A, Cadman L, Mesher D, et al. HPV self-sampling as an alternative strategy in non-attenders for cervical screening - a randomised controlled trial. Br J Cancer 2011;104:915-20.
12. Giorgi Rossi P, Marsili LM, Camilloni L, et al. The effect of self-sampled HPV testing on participation to cervical cancer screening in Italy: a randomised controlled trial (ISRCTN96071600). Br J Cancer 2011;104:248-54.
13. Dijkstra M, van Niekerk D, Rijkaart D, et al. Primary hrHPV DNA testing in Cervical Cancer screening: how to manage screen positive women? A POBASCAM Trial sub study. Cancer Epidemiol Biomarkers Prev 2014;23:55-63.
14. Rijkaart DC, Berkhof J, van Kemenade FJ, et al. Evaluation of 14 triage strategies for HPV DNA-positive women in population-based cervical screening. Int J Cancer 2012;130:602-10.
15. Steenbergen RDM, Snijders PJF, Heideman DAM, et al. Clinical implications of (epi) genetic changes in HPV-induced cervical precancerous lesions. Nat Rev Cancer 2014;14:395-405.
16. Wentzensen N, Sherman ME, Schiffman M, et al. Utility of methylation markers in cervical cancer early detection: appraisal of the atate-of-the-science. Gynecol Oncol 2009;112:293-99.
17. Tornesello ML, Buonaguro L, Giorgi-Rossi P, et al. Viral and cellular biomarkers in the diagnosis of cervical intraepithelial neoplasia and cancer. Biomed Res Int 2013;2013:519619.
18. Saavedra KF, Brebi PS, Roa JC. Epigenetics alterations in preneoplastic and neoplastic lesions of the cervix. Clin Epigenetics 2012;4:13.
19. Steenbergen RDM, Kramer D, Braakhuis BJM, et al. TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia. J Natl Cancer Inst 2004;96:294-305.
20. Wilting SM, van Boerdonk RAA, Henken FE, et al. Methylation-mediated silencing and tumour suppressive function of hsa-miR-124 in cervical cancer. Mol Cancer 2010;9:167.
21. Overmeer RM, Henken FE, Snijders PJF, et al. Association between dense CADM1 promoter methylation and reduced protein expression in high-grade CIN and cervical SCC. J Pathol 2008;1:388-97.
22. Overmeer RM, Henken FE, Bierkens M, et al. Repression of MAL tumour suppressor activity by promoter methylation during cervical carcinogenesis. J Pathol 2009;219:327-36.
23. Eijsink JJH, Lendvai Á, Deregowski V, et al. A four-gene methylation marker panel as triage test in high-risk human papillomavirus positive patients. Int J Cancer 2012;130:1861-69.
24. Lai H-C, Lin Y-W, Huang R-L, et al. Quantitative DNA methylation analysis detects cervical intraepithelial neoplasms type 3 and worse. Cancer 2010;116:4266-74.
25. Eijsink JJH, Yang N, Lendvai A, et al. Detection of cervical neoplasia by DNA methylation analysis in cervico-vaginal lavages, a feasibility study. Gynecol Oncol 2011;120:280-83.
26. Boers A, Bosgraaf RP, van Leeuwen RW, et al. DNA methylation analysis in self-sampled brush material as a triage test in hrHPV-positive women. Br J Cancer 2014;111:1095-101.
27. Hansel A, Steinbach D, Greinke C, et al. A promising DNA methylation signature for the triage of high-risk human papillomavirus DNA-positive women. PLoS One 2014;9:e91905.
28. Tao MH, Freudenheim JL. DNA methylation in endometrial cancer. Epigenetics 2010;5:491-98.
29. Fukami T, Fukuhara H, Kuramochi M, et al. Promoter methylation of the TSLC1 gene in advanced lung tumors and various cancer cell lines. Int J Cancer 2003;107:53-9.
30. Balch C, Matei DE, Huang TH-M, et al. Role of epigenomics in ovarian and endometrial cancers. Epigenomics 2010;2:419-47.
31. Wentzensen N, Bakkum-Gamez JN, Killian JK, et al. Discovery and validation of methylation markers for endometrial cancer. Int J Cancer 2014;135:1860-68.
32. Overmeer RM, Louwers JA, Meijer CJLM, et al. Combined CADM1 and MAL promoter methylation analysis to detect (pre-)malignant cervical lesions in high-risk HPV-positive women. Int J Cancer 2011;129:2218-25.
33. Hesselink AT, Heideman DAM, Steenbergen RDM, et al. Combined promoter methylation analysis of CADM1 and MAL: an objective triage tool for high-risk human papillomavirus DNA-positive women. Clin Cancer Res 2011;17:2459-65.
34. Hesselink AT, Heideman DAM, Steenbergen RDM, et al. Methylation marker analysis of self-sampled cervico-vaginal lavage specimens to triage high-risk HPV-positive women for colposcopy. Int J Cancer 2014;135:880-86.
35. Verhoef VMJ, Bosgraaf RP, van Kemenade FJ, et al. Triage by methylation-marker testing versus cytology in women who test HPV-positive on self-collected cervicovaginal specimens (PROHTECT-3): a randomised controlled non-inferiority trial. Lancet Oncol 2014;15:315-22.
36. Bierkens M, Hesselink AT, Meijer CJLM, et al. CADM1 and MAL promoter methylation levels in hrHPV-positive cervical scrapes increase proportional to degree and duration of underlying cervical disease. Int J Cancer 2013;133:1293-99.
37. De Strooper LMA, Hesselink AT, Berkhof J, et al. Combined CADM1/MAL Methylation and cytology testing for colposcopy triage of high-risk HPV-positive women. Cancer Epidemiol Biomarkers Prev 2014;23:1933-37.
38. Bulk S, van Kemenade FJ, Rozendaal L, et al. The dutch CISOE-A framework for cytology reporting increases efficacy of screening upon standardisation since 1996. J Clin Pathol 2004;57:388-93.
39. Van Den Brule AJC, Pol R, Fransen-Daalmeijer N, et al. GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol 2002;40:779-87.
40. Federation of Biomedical Scientific Societies. Human tissue and medical research: code of conduct for responsible use. 2011. http://www.federa.org/sites/default/files/digital-version-first-part-code-of-conduct-in-uk-2011-12092012.pdf (accessed 24 Jun 2014).
41. Snellenberg S, De Strooper LMA, Hesselink AT, et al. Development of a multiplex methylation-specific PCR as candidate triage test for women with an HPV-positive cervical scrape. BMC Cancer 2012;12:551.
42. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative CT method. Nat Protoc 2008;3:1101-8.
43. Li N, Franceschi S, Howell-Jones R, et al. Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication. Int J Cancer 2011;128:927-35.
44. Kinde I, Bettegowda C, Wang Y, et al. Evaluation of DNA from the Papanicolaou test to detect ovarian and endometrial cancers. Sci Transl Med 2013;5:167ra4.
45. Lin H, Chen T-C, Chang T-C, et al. Methylated ZNF582 gene as a marker for triage of women with Pap smear reporting low-grade squamous intraepithelial lesions - A Taiwanese Gynecologic Oncology Group (TGOG) study. Gynecol Oncol 2014 (in press).
46. VasiljevićN, Scibior-Bentkowska D, Brentnall AR, et al. Credentialing of DNA methylation assays for human genes as diagnostic biomarkers of cervical intraepithelial neoplasia in high-risk HPV positive women. Gynecol Oncol 2014;132:709-14.